Product Information
BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $10.0787 per ML under NDC 00781601485. Its NADAC has been published 253 times since Oct 20, 2021.
FDA first approved this application on Apr 1, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Sandoz Inc.NDC
00781601485
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BRINZOLAMIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020816FDA Approved
4/1/1998
TE Code
AB
On Market Since
3/8/2021
Pharmacological Classes
Price Statistics
The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 253 times since Oct 20, 2021, and over the history we have for it it has declined 52.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.0787 per ML |
|---|---|
| All-time high | $28.2727 (Mar 16, 2022) |
| All-time low | $7.2636 (May 22, 2024) |
| 52-week high | $14.3013 |
| 52-week low | $10.0787 |
| Median price | $13.2208 |
| Average price | $15.4791 |
| Largest weekly change | +58.3% (May 17, 2023) |
| Weeks tracked | 253 |
| Tracking since | Oct 20, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Sandoz Inc., is $10.0787 per ML (NDC 00781601485), effective Aug 19, 2026.
How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 52.2%. It has been tracked across 253 weekly CMS publications since Oct 20, 2021.
What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?
Since Oct 20, 2021, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $7.2636 (May 22, 2024) to a high of $28.2727 (Mar 16, 2022), with a median of $13.2208 per ML.
Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRINZOLAMIDE 1% EYE DROPS, is $9.4893 per ML — about 6% below BRINZOLAMIDE 1% EYE DROPS.
Who manufactures BRINZOLAMIDE 1% EYE DROPS?
BRINZOLAMIDE 1% EYE DROPS (NDC 00781601485) is labeled by Sandoz Inc., and CMS classifies it as a generic product.